Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children’s Oncology Group AREN0321 Study

Najat C. Daw,Yueh Yun Chi,John A. Kalapurakal,Yeonil Kim,Fredric A. Hoffer,James I. Geller,Elizabeth J. Perlman,Peter F. Ehrlich,Elizabeth Mullen,Anne B. Warwick,Paul E. Grundy,Arnold C. Paulino,Eric J. Gratias,Deborah A. Ward,James R. Anderson,Geetika Khanna,Brett Tornwall,Conrad V. Fernandez,Jeffrey S. Dome

Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children’s Oncology Group AREN0321 Study

2020

Najat C. Daw
Yueh Yun Chi
John A. Kalapurakal
Yeonil Kim
Fredric A. Hoffer
James I. Geller
Elizabeth J. Perlman
Peter F. Ehrlich
Elizabeth Mullen
Anne B. Warwick
Paul E. Grundy
Arnold C. Paulino
Eric J. Gratias
Deborah A. Ward
James R. Anderson
Geetika Khanna
Brett Tornwall
Conrad V. Fernandez
Jeffrey S. Dome

PURPOSEAREN0321 evaluated the activity of vincristine and irinotecan (VI) in patients with newly diagnosed diffuse anaplastic Wilms tumor (DAWT) and whether a regimen containing carboplatin (regime...

Keywords:

Oncology
Vincristine
Disease
Regimen
Irinotecan
Wilms' tumor
Carboplatin
Medicine
Internal medicine
stage ii
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations